Cargando…
Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions
Introduction: Regulatory agencies encourage the incorporation of the patient voices throughout clinical drug development. Patient-Reported Outcomes (PROs) offer one way of doing this and their use has markedly increased in many therapeutic areas, particularly oncology, in recent years. However, few...
Autores principales: | Cella, David, Chen, Chieh-I, Quek, Ruben G. W., Uribarren, Ainhoa, Reaney, Matthew, Mastey, Vera, Collyar, Deborah, Chassany, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634749/ https://www.ncbi.nlm.nih.gov/pubmed/36339622 http://dx.doi.org/10.3389/fphar.2022.1031992 |
Ejemplares similares
-
Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
por: Chua, E. W., et al.
Publicado: (2012) -
Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022) -
Adenosine Receptor-Mediated Cardioprotection—Current Limitations and Future Directions
por: Lasley, Robert D.
Publicado: (2018) -
Cellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
por: Docherty, Marie Helena, et al.
Publicado: (2020) -
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
por: Shams, Shahin, et al.
Publicado: (2021)